Global Avian Influenza Vaccines Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Avian Influenza Vaccines market size is predicted to grow from US$ 1076 million in 2025 to US$ 1501 million in 2031; it is expected to grow at a CAGR of 5.7% from 2025 to 2031.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
The avian influenza vaccines market is driven by the increasing prevalence of avian flu outbreaks, which pose significant threats to both poultry industries and public health. As global poultry consumption rises, the need to protect livestock from highly pathogenic avian influenza strains is critical to maintaining food security and preventing economic losses. Governments and regulatory bodies are increasingly focused on preventing zoonotic transmission, leading to the widespread use of vaccines in poultry farms. Additionally, ongoing advancements in vaccine development, such as more effective and faster-acting vaccines, are further driving market growth.
A major challenge in the avian influenza vaccines market is the high cost and logistical difficulties of mass vaccination programs, especially in large-scale poultry farms or regions with limited veterinary infrastructure. The need for continuous monitoring and re-vaccination due to the evolving nature of avian influenza strains adds to the complexity and cost of vaccine deployment. Additionally, regulatory barriers and varying standards for vaccine approval across different countries can hinder the global distribution of vaccines, limiting market expansion in certain regions.
Global Avian Influenza Vaccines key players include Boehringer Ingelheim, CAHIC, DHN, HVRI, etc. Global top five manufacturers hold a share over 70%. China is the largest market, with a share about 45%. In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.
LP Information, Inc. (LPI) ' newest research report, the “Avian Influenza Vaccines Industry Forecast” looks at past sales and reviews total world Avian Influenza Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Avian Influenza Vaccines sales for 2025 through 2031. With Avian Influenza Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Avian Influenza Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Avian Influenza Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Avian Influenza Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Avian Influenza Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Avian Influenza Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Avian Influenza Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Avian Influenza Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Avian Influenza Vaccines market?
What factors are driving Avian Influenza Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Avian Influenza Vaccines market opportunities vary by end market size?
How does Avian Influenza Vaccines break out by Type, by Application?
The global Avian Influenza Vaccines market size is predicted to grow from US$ 1076 million in 2025 to US$ 1501 million in 2031; it is expected to grow at a CAGR of 5.7% from 2025 to 2031.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
The avian influenza vaccines market is driven by the increasing prevalence of avian flu outbreaks, which pose significant threats to both poultry industries and public health. As global poultry consumption rises, the need to protect livestock from highly pathogenic avian influenza strains is critical to maintaining food security and preventing economic losses. Governments and regulatory bodies are increasingly focused on preventing zoonotic transmission, leading to the widespread use of vaccines in poultry farms. Additionally, ongoing advancements in vaccine development, such as more effective and faster-acting vaccines, are further driving market growth.
A major challenge in the avian influenza vaccines market is the high cost and logistical difficulties of mass vaccination programs, especially in large-scale poultry farms or regions with limited veterinary infrastructure. The need for continuous monitoring and re-vaccination due to the evolving nature of avian influenza strains adds to the complexity and cost of vaccine deployment. Additionally, regulatory barriers and varying standards for vaccine approval across different countries can hinder the global distribution of vaccines, limiting market expansion in certain regions.
Global Avian Influenza Vaccines key players include Boehringer Ingelheim, CAHIC, DHN, HVRI, etc. Global top five manufacturers hold a share over 70%. China is the largest market, with a share about 45%. In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.
LP Information, Inc. (LPI) ' newest research report, the “Avian Influenza Vaccines Industry Forecast” looks at past sales and reviews total world Avian Influenza Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Avian Influenza Vaccines sales for 2025 through 2031. With Avian Influenza Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Avian Influenza Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Avian Influenza Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Avian Influenza Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Avian Influenza Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Avian Influenza Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Avian Influenza Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Avian Influenza Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- H5+H7 Avian Influenza Vaccines
- H9 Avian Influenza Vaccines
- Chicken
- Duck & Goose
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- CAHIC
- DHN
- HVRI
- CEVA
- Elanco Animal Health
- Zoetis
- FATRO
- Kyoto Biken
- CAVAC
- Ringpu Biology
- Vaksindo
- Sindh Poultry Vaccine Centre
- Merck Animal Health
- PT Medion Farma Jaya
- Avimex Animal Health
- JOVAC
- Bio-Labs
- Pusvetma
- IPB-Shigeta
- Medion Farma Jaya
- Caprifamarindo
What is the 10-year outlook for the global Avian Influenza Vaccines market?
What factors are driving Avian Influenza Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Avian Influenza Vaccines market opportunities vary by end market size?
How does Avian Influenza Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Avian Influenza Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Avian Influenza Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Avian Influenza Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Avian Influenza Vaccines Segment by Type
2.2.1 H5+H7 Avian Influenza Vaccines
2.2.2 H9 Avian Influenza Vaccines
2.3 Avian Influenza Vaccines Sales by Type
2.3.1 Global Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Avian Influenza Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Avian Influenza Vaccines Sale Price by Type (2020-2025)
2.4 Avian Influenza Vaccines Segment by Application
2.4.1 Chicken
2.4.2 Duck & Goose
2.4.3 Other
2.5 Avian Influenza Vaccines Sales by Application
2.5.1 Global Avian Influenza Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Avian Influenza Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Avian Influenza Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Avian Influenza Vaccines Breakdown Data by Company
3.1.1 Global Avian Influenza Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Avian Influenza Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Avian Influenza Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Avian Influenza Vaccines Revenue by Company (2020-2025)
3.2.2 Global Avian Influenza Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Avian Influenza Vaccines Sale Price by Company
3.4 Key Manufacturers Avian Influenza Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Avian Influenza Vaccines Product Location Distribution
3.4.2 Players Avian Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AVIAN INFLUENZA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Avian Influenza Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Avian Influenza Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Avian Influenza Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Avian Influenza Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Avian Influenza Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Avian Influenza Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Avian Influenza Vaccines Sales Growth
4.4 APAC Avian Influenza Vaccines Sales Growth
4.5 Europe Avian Influenza Vaccines Sales Growth
4.6 Middle East & Africa Avian Influenza Vaccines Sales Growth
5 AMERICAS
5.1 Americas Avian Influenza Vaccines Sales by Country
5.1.1 Americas Avian Influenza Vaccines Sales by Country (2020-2025)
5.1.2 Americas Avian Influenza Vaccines Revenue by Country (2020-2025)
5.2 Americas Avian Influenza Vaccines Sales by Type (2020-2025)
5.3 Americas Avian Influenza Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Avian Influenza Vaccines Sales by Region
6.1.1 APAC Avian Influenza Vaccines Sales by Region (2020-2025)
6.1.2 APAC Avian Influenza Vaccines Revenue by Region (2020-2025)
6.2 APAC Avian Influenza Vaccines Sales by Type (2020-2025)
6.3 APAC Avian Influenza Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Avian Influenza Vaccines by Country
7.1.1 Europe Avian Influenza Vaccines Sales by Country (2020-2025)
7.1.2 Europe Avian Influenza Vaccines Revenue by Country (2020-2025)
7.2 Europe Avian Influenza Vaccines Sales by Type (2020-2025)
7.3 Europe Avian Influenza Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Avian Influenza Vaccines by Country
8.1.1 Middle East & Africa Avian Influenza Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Avian Influenza Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Avian Influenza Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Avian Influenza Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Avian Influenza Vaccines
10.3 Manufacturing Process Analysis of Avian Influenza Vaccines
10.4 Industry Chain Structure of Avian Influenza Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Avian Influenza Vaccines Distributors
11.3 Avian Influenza Vaccines Customer
12 WORLD FORECAST REVIEW FOR AVIAN INFLUENZA VACCINES BY GEOGRAPHIC REGION
12.1 Global Avian Influenza Vaccines Market Size Forecast by Region
12.1.1 Global Avian Influenza Vaccines Forecast by Region (2026-2031)
12.1.2 Global Avian Influenza Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Avian Influenza Vaccines Forecast by Type (2026-2031)
12.7 Global Avian Influenza Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Avian Influenza Vaccines Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 CAHIC
13.2.1 CAHIC Company Information
13.2.2 CAHIC Avian Influenza Vaccines Product Portfolios and Specifications
13.2.3 CAHIC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CAHIC Main Business Overview
13.2.5 CAHIC Latest Developments
13.3 DHN
13.3.1 DHN Company Information
13.3.2 DHN Avian Influenza Vaccines Product Portfolios and Specifications
13.3.3 DHN Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 DHN Main Business Overview
13.3.5 DHN Latest Developments
13.4 HVRI
13.4.1 HVRI Company Information
13.4.2 HVRI Avian Influenza Vaccines Product Portfolios and Specifications
13.4.3 HVRI Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 HVRI Main Business Overview
13.4.5 HVRI Latest Developments
13.5 CEVA
13.5.1 CEVA Company Information
13.5.2 CEVA Avian Influenza Vaccines Product Portfolios and Specifications
13.5.3 CEVA Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CEVA Main Business Overview
13.5.5 CEVA Latest Developments
13.6 Elanco Animal Health
13.6.1 Elanco Animal Health Company Information
13.6.2 Elanco Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
13.6.3 Elanco Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Elanco Animal Health Main Business Overview
13.6.5 Elanco Animal Health Latest Developments
13.7 Zoetis
13.7.1 Zoetis Company Information
13.7.2 Zoetis Avian Influenza Vaccines Product Portfolios and Specifications
13.7.3 Zoetis Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Zoetis Main Business Overview
13.7.5 Zoetis Latest Developments
13.8 FATRO
13.8.1 FATRO Company Information
13.8.2 FATRO Avian Influenza Vaccines Product Portfolios and Specifications
13.8.3 FATRO Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 FATRO Main Business Overview
13.8.5 FATRO Latest Developments
13.9 Kyoto Biken
13.9.1 Kyoto Biken Company Information
13.9.2 Kyoto Biken Avian Influenza Vaccines Product Portfolios and Specifications
13.9.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Kyoto Biken Main Business Overview
13.9.5 Kyoto Biken Latest Developments
13.10 CAVAC
13.10.1 CAVAC Company Information
13.10.2 CAVAC Avian Influenza Vaccines Product Portfolios and Specifications
13.10.3 CAVAC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 CAVAC Main Business Overview
13.10.5 CAVAC Latest Developments
13.11 Ringpu Biology
13.11.1 Ringpu Biology Company Information
13.11.2 Ringpu Biology Avian Influenza Vaccines Product Portfolios and Specifications
13.11.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Ringpu Biology Main Business Overview
13.11.5 Ringpu Biology Latest Developments
13.12 Vaksindo
13.12.1 Vaksindo Company Information
13.12.2 Vaksindo Avian Influenza Vaccines Product Portfolios and Specifications
13.12.3 Vaksindo Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Vaksindo Main Business Overview
13.12.5 Vaksindo Latest Developments
13.13 Sindh Poultry Vaccine Centre
13.13.1 Sindh Poultry Vaccine Centre Company Information
13.13.2 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolios and Specifications
13.13.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Sindh Poultry Vaccine Centre Main Business Overview
13.13.5 Sindh Poultry Vaccine Centre Latest Developments
13.14 Merck Animal Health
13.14.1 Merck Animal Health Company Information
13.14.2 Merck Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
13.14.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Merck Animal Health Main Business Overview
13.14.5 Merck Animal Health Latest Developments
13.15 PT Medion Farma Jaya
13.15.1 PT Medion Farma Jaya Company Information
13.15.2 PT Medion Farma Jaya Avian Influenza Vaccines Product Portfolios and Specifications
13.15.3 PT Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 PT Medion Farma Jaya Main Business Overview
13.15.5 PT Medion Farma Jaya Latest Developments
13.16 Avimex Animal Health
13.16.1 Avimex Animal Health Company Information
13.16.2 Avimex Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
13.16.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Avimex Animal Health Main Business Overview
13.16.5 Avimex Animal Health Latest Developments
13.17 JOVAC
13.17.1 JOVAC Company Information
13.17.2 JOVAC Avian Influenza Vaccines Product Portfolios and Specifications
13.17.3 JOVAC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 JOVAC Main Business Overview
13.17.5 JOVAC Latest Developments
13.18 Bio-Labs
13.18.1 Bio-Labs Company Information
13.18.2 Bio-Labs Avian Influenza Vaccines Product Portfolios and Specifications
13.18.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Bio-Labs Main Business Overview
13.18.5 Bio-Labs Latest Developments
13.19 Pusvetma
13.19.1 Pusvetma Company Information
13.19.2 Pusvetma Avian Influenza Vaccines Product Portfolios and Specifications
13.19.3 Pusvetma Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Pusvetma Main Business Overview
13.19.5 Pusvetma Latest Developments
13.20 IPB-Shigeta
13.20.1 IPB-Shigeta Company Information
13.20.2 IPB-Shigeta Avian Influenza Vaccines Product Portfolios and Specifications
13.20.3 IPB-Shigeta Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 IPB-Shigeta Main Business Overview
13.20.5 IPB-Shigeta Latest Developments
13.21 Medion Farma Jaya
13.21.1 Medion Farma Jaya Company Information
13.21.2 Medion Farma Jaya Avian Influenza Vaccines Product Portfolios and Specifications
13.21.3 Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Medion Farma Jaya Main Business Overview
13.21.5 Medion Farma Jaya Latest Developments
13.22 Caprifamarindo
13.22.1 Caprifamarindo Company Information
13.22.2 Caprifamarindo Avian Influenza Vaccines Product Portfolios and Specifications
13.22.3 Caprifamarindo Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Caprifamarindo Main Business Overview
13.22.5 Caprifamarindo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Avian Influenza Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Avian Influenza Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of H5+H7 Avian Influenza Vaccines
Table 4. Major Players of H9 Avian Influenza Vaccines
Table 5. Global Avian Influenza Vaccines Sales byType (2020-2025) & (M Doses)
Table 6. Global Avian Influenza Vaccines Sales Market Share byType (2020-2025)
Table 7. Global Avian Influenza Vaccines Revenue byType (2020-2025) & ($ million)
Table 8. Global Avian Influenza Vaccines Revenue Market Share byType (2020-2025)
Table 9. Global Avian Influenza Vaccines Sale Price byType (2020-2025) & (USD/K Doses)
Table 10. Global Avian Influenza Vaccines Sale by Application (2020-2025) & (M Doses)
Table 11. Global Avian Influenza Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global Avian Influenza Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global Avian Influenza Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global Avian Influenza Vaccines Sale Price by Application (2020-2025) & (USD/K Doses)
Table 15. Global Avian Influenza Vaccines Sales by Company (2020-2025) & (M Doses)
Table 16. Global Avian Influenza Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global Avian Influenza Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Avian Influenza Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global Avian Influenza Vaccines Sale Price by Company (2020-2025) & (USD/K Doses)
Table 20. Key Manufacturers Avian Influenza Vaccines Producing Area Distribution and Sales Area
Table 21. Players Avian Influenza Vaccines Products Offered
Table 22. Avian Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Avian Influenza Vaccines Sales by Geographic Region (2020-2025) & (M Doses)
Table 26. Global Avian Influenza Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global Avian Influenza Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Avian Influenza Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Avian Influenza Vaccines Sales by Country/Region (2020-2025) & (M Doses)
Table 30. Global Avian Influenza Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global Avian Influenza Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Avian Influenza Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 34. Americas Avian Influenza Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas Avian Influenza Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Avian Influenza Vaccines Sales byType (2020-2025) & (M Doses)
Table 37. Americas Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 38. APAC Avian Influenza Vaccines Sales by Region (2020-2025) & (M Doses)
Table 39. APAC Avian Influenza Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC Avian Influenza Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Avian Influenza Vaccines Sales byType (2020-2025) & (M Doses)
Table 42. APAC Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 43. Europe Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 44. Europe Avian Influenza Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Avian Influenza Vaccines Sales byType (2020-2025) & (M Doses)
Table 46. Europe Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 47. Middle East & Africa Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 48. Middle East & Africa Avian Influenza Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Avian Influenza Vaccines Sales byType (2020-2025) & (M Doses)
Table 50. Middle East & Africa Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of Avian Influenza Vaccines
Table 52. Key Market Challenges & Risks of Avian Influenza Vaccines
Table 53. Key IndustryTrends of Avian Influenza Vaccines
Table 54. Avian Influenza Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Avian Influenza Vaccines Distributors List
Table 57. Avian Influenza Vaccines Customer List
Table 58. Global Avian Influenza Vaccines SalesForecast by Region (2026-2031) & (M Doses)
Table 59. Global Avian Influenza Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Avian Influenza Vaccines SalesForecast by Country (2026-2031) & (M Doses)
Table 61. Americas Avian Influenza Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Avian Influenza Vaccines SalesForecast by Region (2026-2031) & (M Doses)
Table 63. APAC Avian Influenza Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Avian Influenza Vaccines SalesForecast by Country (2026-2031) & (M Doses)
Table 65. Europe Avian Influenza Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Avian Influenza Vaccines SalesForecast by Country (2026-2031) & (M Doses)
Table 67. Middle East & Africa Avian Influenza Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Avian Influenza Vaccines SalesForecast byType (2026-2031) & (M Doses)
Table 69. Global Avian Influenza Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Avian Influenza Vaccines SalesForecast by Application (2026-2031) & (M Doses)
Table 71. Global Avian Influenza Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Boehringer Ingelheim Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Boehringer Ingelheim Avian Influenza Vaccines Product Portfolios and Specifications
Table 74. Boehringer Ingelheim Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 75. Boehringer Ingelheim Main Business
Table 76. Boehringer Ingelheim Latest Developments
Table 77. CAHIC Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. CAHIC Avian Influenza Vaccines Product Portfolios and Specifications
Table 79. CAHIC Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. CAHIC Main Business
Table 81. CAHIC Latest Developments
Table 82. DHN Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. DHN Avian Influenza Vaccines Product Portfolios and Specifications
Table 84. DHN Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 85. DHN Main Business
Table 86. DHN Latest Developments
Table 87. HVRI Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. HVRI Avian Influenza Vaccines Product Portfolios and Specifications
Table 89. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 90. HVRI Main Business
Table 91. HVRI Latest Developments
Table 92. CEVA Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. CEVA Avian Influenza Vaccines Product Portfolios and Specifications
Table 94. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 95. CEVA Main Business
Table 96. CEVA Latest Developments
Table 97. Elanco Animal Health Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Elanco Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
Table 99. Elanco Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 100. Elanco Animal Health Main Business
Table 101. Elanco Animal Health Latest Developments
Table 102. Zoetis Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Zoetis Avian Influenza Vaccines Product Portfolios and Specifications
Table 104. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 105. Zoetis Main Business
Table 106. Zoetis Latest Developments
Table 107.FATRO Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108.FATRO Avian Influenza Vaccines Product Portfolios and Specifications
Table 109.FATRO Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 110.FATRO Main Business
Table 111.FATRO Latest Developments
Table 112. Kyoto Biken Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Kyoto Biken Avian Influenza Vaccines Product Portfolios and Specifications
Table 114. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 115. Kyoto Biken Main Business
Table 116. Kyoto Biken Latest Developments
Table 117. CAVAC Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. CAVAC Avian Influenza Vaccines Product Portfolios and Specifications
Table 119. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. CAVAC Main Business
Table 121. CAVAC Latest Developments
Table 122. Ringpu Biology Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Ringpu Biology Avian Influenza Vaccines Product Portfolios and Specifications
Table 124. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 125. Ringpu Biology Main Business
Table 126. Ringpu Biology Latest Developments
Table 127. Vaksindo Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Vaksindo Avian Influenza Vaccines Product Portfolios and Specifications
Table 129. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 130. Vaksindo Main Business
Table 131. Vaksindo Latest Developments
Table 132. Sindh Poultry Vaccine Centre Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolios and Specifications
Table 134. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 135. Sindh Poultry Vaccine Centre Main Business
Table 136. Sindh Poultry Vaccine Centre Latest Developments
Table 137. Merck Animal Health Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. Merck Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
Table 139. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 140. Merck Animal Health Main Business
Table 141. Merck Animal Health Latest Developments
Table 142. PT MedionFarma Jaya Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. PT MedionFarma Jaya Avian Influenza Vaccines Product Portfolios and Specifications
Table 144. PT MedionFarma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 145. PT MedionFarma Jaya Main Business
Table 146. PT MedionFarma Jaya Latest Developments
Table 147. Avimex Animal Health Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. Avimex Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
Table 149. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 150. Avimex Animal Health Main Business
Table 151. Avimex Animal Health Latest Developments
Table 152. JOVAC Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 153. JOVAC Avian Influenza Vaccines Product Portfolios and Specifications
Table 154. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 155. JOVAC Main Business
Table 156. JOVAC Latest Developments
Table 157. Bio-Labs Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 158. Bio-Labs Avian Influenza Vaccines Product Portfolios and Specifications
Table 159. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 160. Bio-Labs Main Business
Table 161. Bio-Labs Latest Developments
Table 162. Pusvetma Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 163. Pusvetma Avian Influenza Vaccines Product Portfolios and Specifications
Table 164. Pusvetma Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 165. Pusvetma Main Business
Table 166. Pusvetma Latest Developments
Table 167. IPB-Shigeta Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 168. IPB-Shigeta Avian Influenza Vaccines Product Portfolios and Specifications
Table 169. IPB-Shigeta Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 170. IPB-Shigeta Main Business
Table 171. IPB-Shigeta Latest Developments
Table 172. MedionFarma Jaya Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 173. MedionFarma Jaya Avian Influenza Vaccines Product Portfolios and Specifications
Table 174. MedionFarma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 175. MedionFarma Jaya Main Business
Table 176. MedionFarma Jaya Latest Developments
Table 177. Caprifamarindo Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 178. Caprifamarindo Avian Influenza Vaccines Product Portfolios and Specifications
Table 179. Caprifamarindo Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 180. Caprifamarindo Main Business
Table 181. Caprifamarindo Latest Developments
LIST OFFIGURES
Figure 1. Picture of Avian Influenza Vaccines
Figure 2. Avian Influenza Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Avian Influenza Vaccines Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Avian Influenza Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Avian Influenza Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Avian Influenza Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Avian Influenza Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of H5+H7 Avian Influenza Vaccines
Figure 12. Product Picture of H9 Avian Influenza Vaccines
Figure 13. Global Avian Influenza Vaccines Sales Market Share byType in 2025
Figure 14. Global Avian Influenza Vaccines Revenue Market Share byType (2020-2025)
Figure 15. Avian Influenza Vaccines Consumed in Chicken
Figure 16. Global Avian Influenza Vaccines Market: Chicken (2020-2025) & (M Doses)
Figure 17. Avian Influenza Vaccines Consumed in Duck & Goose
Figure 18. Global Avian Influenza Vaccines Market: Duck & Goose (2020-2025) & (M Doses)
Figure 19. Avian Influenza Vaccines Consumed in Other
Figure 20. Global Avian Influenza Vaccines Market: Other (2020-2025) & (M Doses)
Figure 21. Global Avian Influenza Vaccines Sale Market Share by Application (2024)
Figure 22. Global Avian Influenza Vaccines Revenue Market Share by Application in 2025
Figure 23. Avian Influenza Vaccines Sales by Company in 2025 (M Doses)
Figure 24. Global Avian Influenza Vaccines Sales Market Share by Company in 2025
Figure 25. Avian Influenza Vaccines Revenue by Company in 2025 ($ millions)
Figure 26. Global Avian Influenza Vaccines Revenue Market Share by Company in 2025
Figure 27. Global Avian Influenza Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Avian Influenza Vaccines Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Avian Influenza Vaccines Sales 2020-2025 (M Doses)
Figure 30. Americas Avian Influenza Vaccines Revenue 2020-2025 ($ millions)
Figure 31. APAC Avian Influenza Vaccines Sales 2020-2025 (M Doses)
Figure 32. APAC Avian Influenza Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Europe Avian Influenza Vaccines Sales 2020-2025 (M Doses)
Figure 34. Europe Avian Influenza Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Avian Influenza Vaccines Sales 2020-2025 (M Doses)
Figure 36. Middle East & Africa Avian Influenza Vaccines Revenue 2020-2025 ($ millions)
Figure 37. Americas Avian Influenza Vaccines Sales Market Share by Country in 2025
Figure 38. Americas Avian Influenza Vaccines Revenue Market Share by Country (2020-2025)
Figure 39. Americas Avian Influenza Vaccines Sales Market Share byType (2020-2025)
Figure 40. Americas Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 41. United States Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Avian Influenza Vaccines Sales Market Share by Region in 2025
Figure 46. APAC Avian Influenza Vaccines Revenue Market Share by Region (2020-2025)
Figure 47. APAC Avian Influenza Vaccines Sales Market Share byType (2020-2025)
Figure 48. APAC Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 49. China Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. India Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Avian Influenza Vaccines Sales Market Share by Country in 2025
Figure 57. Europe Avian Influenza Vaccines Revenue Market Share by Country (2020-2025)
Figure 58. Europe Avian Influenza Vaccines Sales Market Share byType (2020-2025)
Figure 59. Europe Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 60. Germany Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61.France Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Avian Influenza Vaccines Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Avian Influenza Vaccines Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 68. Egypt Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Avian Influenza Vaccines in 2025
Figure 74. Manufacturing Process Analysis of Avian Influenza Vaccines
Figure 75. Industry Chain Structure of Avian Influenza Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Avian Influenza Vaccines Sales MarketForecast by Region (2026-2031)
Figure 78. Global Avian Influenza Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Avian Influenza Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Avian Influenza Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Avian Influenza Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Avian Influenza Vaccines Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Avian Influenza Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Avian Influenza Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Avian Influenza Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Avian Influenza Vaccines Segment by Type
2.2.1 H5+H7 Avian Influenza Vaccines
2.2.2 H9 Avian Influenza Vaccines
2.3 Avian Influenza Vaccines Sales by Type
2.3.1 Global Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Avian Influenza Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Avian Influenza Vaccines Sale Price by Type (2020-2025)
2.4 Avian Influenza Vaccines Segment by Application
2.4.1 Chicken
2.4.2 Duck & Goose
2.4.3 Other
2.5 Avian Influenza Vaccines Sales by Application
2.5.1 Global Avian Influenza Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Avian Influenza Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Avian Influenza Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Avian Influenza Vaccines Breakdown Data by Company
3.1.1 Global Avian Influenza Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Avian Influenza Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Avian Influenza Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Avian Influenza Vaccines Revenue by Company (2020-2025)
3.2.2 Global Avian Influenza Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Avian Influenza Vaccines Sale Price by Company
3.4 Key Manufacturers Avian Influenza Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Avian Influenza Vaccines Product Location Distribution
3.4.2 Players Avian Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AVIAN INFLUENZA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Avian Influenza Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Avian Influenza Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Avian Influenza Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Avian Influenza Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Avian Influenza Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Avian Influenza Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Avian Influenza Vaccines Sales Growth
4.4 APAC Avian Influenza Vaccines Sales Growth
4.5 Europe Avian Influenza Vaccines Sales Growth
4.6 Middle East & Africa Avian Influenza Vaccines Sales Growth
5 AMERICAS
5.1 Americas Avian Influenza Vaccines Sales by Country
5.1.1 Americas Avian Influenza Vaccines Sales by Country (2020-2025)
5.1.2 Americas Avian Influenza Vaccines Revenue by Country (2020-2025)
5.2 Americas Avian Influenza Vaccines Sales by Type (2020-2025)
5.3 Americas Avian Influenza Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Avian Influenza Vaccines Sales by Region
6.1.1 APAC Avian Influenza Vaccines Sales by Region (2020-2025)
6.1.2 APAC Avian Influenza Vaccines Revenue by Region (2020-2025)
6.2 APAC Avian Influenza Vaccines Sales by Type (2020-2025)
6.3 APAC Avian Influenza Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Avian Influenza Vaccines by Country
7.1.1 Europe Avian Influenza Vaccines Sales by Country (2020-2025)
7.1.2 Europe Avian Influenza Vaccines Revenue by Country (2020-2025)
7.2 Europe Avian Influenza Vaccines Sales by Type (2020-2025)
7.3 Europe Avian Influenza Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Avian Influenza Vaccines by Country
8.1.1 Middle East & Africa Avian Influenza Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Avian Influenza Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Avian Influenza Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Avian Influenza Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Avian Influenza Vaccines
10.3 Manufacturing Process Analysis of Avian Influenza Vaccines
10.4 Industry Chain Structure of Avian Influenza Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Avian Influenza Vaccines Distributors
11.3 Avian Influenza Vaccines Customer
12 WORLD FORECAST REVIEW FOR AVIAN INFLUENZA VACCINES BY GEOGRAPHIC REGION
12.1 Global Avian Influenza Vaccines Market Size Forecast by Region
12.1.1 Global Avian Influenza Vaccines Forecast by Region (2026-2031)
12.1.2 Global Avian Influenza Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Avian Influenza Vaccines Forecast by Type (2026-2031)
12.7 Global Avian Influenza Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Avian Influenza Vaccines Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 CAHIC
13.2.1 CAHIC Company Information
13.2.2 CAHIC Avian Influenza Vaccines Product Portfolios and Specifications
13.2.3 CAHIC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CAHIC Main Business Overview
13.2.5 CAHIC Latest Developments
13.3 DHN
13.3.1 DHN Company Information
13.3.2 DHN Avian Influenza Vaccines Product Portfolios and Specifications
13.3.3 DHN Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 DHN Main Business Overview
13.3.5 DHN Latest Developments
13.4 HVRI
13.4.1 HVRI Company Information
13.4.2 HVRI Avian Influenza Vaccines Product Portfolios and Specifications
13.4.3 HVRI Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 HVRI Main Business Overview
13.4.5 HVRI Latest Developments
13.5 CEVA
13.5.1 CEVA Company Information
13.5.2 CEVA Avian Influenza Vaccines Product Portfolios and Specifications
13.5.3 CEVA Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CEVA Main Business Overview
13.5.5 CEVA Latest Developments
13.6 Elanco Animal Health
13.6.1 Elanco Animal Health Company Information
13.6.2 Elanco Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
13.6.3 Elanco Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Elanco Animal Health Main Business Overview
13.6.5 Elanco Animal Health Latest Developments
13.7 Zoetis
13.7.1 Zoetis Company Information
13.7.2 Zoetis Avian Influenza Vaccines Product Portfolios and Specifications
13.7.3 Zoetis Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Zoetis Main Business Overview
13.7.5 Zoetis Latest Developments
13.8 FATRO
13.8.1 FATRO Company Information
13.8.2 FATRO Avian Influenza Vaccines Product Portfolios and Specifications
13.8.3 FATRO Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 FATRO Main Business Overview
13.8.5 FATRO Latest Developments
13.9 Kyoto Biken
13.9.1 Kyoto Biken Company Information
13.9.2 Kyoto Biken Avian Influenza Vaccines Product Portfolios and Specifications
13.9.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Kyoto Biken Main Business Overview
13.9.5 Kyoto Biken Latest Developments
13.10 CAVAC
13.10.1 CAVAC Company Information
13.10.2 CAVAC Avian Influenza Vaccines Product Portfolios and Specifications
13.10.3 CAVAC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 CAVAC Main Business Overview
13.10.5 CAVAC Latest Developments
13.11 Ringpu Biology
13.11.1 Ringpu Biology Company Information
13.11.2 Ringpu Biology Avian Influenza Vaccines Product Portfolios and Specifications
13.11.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Ringpu Biology Main Business Overview
13.11.5 Ringpu Biology Latest Developments
13.12 Vaksindo
13.12.1 Vaksindo Company Information
13.12.2 Vaksindo Avian Influenza Vaccines Product Portfolios and Specifications
13.12.3 Vaksindo Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Vaksindo Main Business Overview
13.12.5 Vaksindo Latest Developments
13.13 Sindh Poultry Vaccine Centre
13.13.1 Sindh Poultry Vaccine Centre Company Information
13.13.2 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolios and Specifications
13.13.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Sindh Poultry Vaccine Centre Main Business Overview
13.13.5 Sindh Poultry Vaccine Centre Latest Developments
13.14 Merck Animal Health
13.14.1 Merck Animal Health Company Information
13.14.2 Merck Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
13.14.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Merck Animal Health Main Business Overview
13.14.5 Merck Animal Health Latest Developments
13.15 PT Medion Farma Jaya
13.15.1 PT Medion Farma Jaya Company Information
13.15.2 PT Medion Farma Jaya Avian Influenza Vaccines Product Portfolios and Specifications
13.15.3 PT Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 PT Medion Farma Jaya Main Business Overview
13.15.5 PT Medion Farma Jaya Latest Developments
13.16 Avimex Animal Health
13.16.1 Avimex Animal Health Company Information
13.16.2 Avimex Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
13.16.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Avimex Animal Health Main Business Overview
13.16.5 Avimex Animal Health Latest Developments
13.17 JOVAC
13.17.1 JOVAC Company Information
13.17.2 JOVAC Avian Influenza Vaccines Product Portfolios and Specifications
13.17.3 JOVAC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 JOVAC Main Business Overview
13.17.5 JOVAC Latest Developments
13.18 Bio-Labs
13.18.1 Bio-Labs Company Information
13.18.2 Bio-Labs Avian Influenza Vaccines Product Portfolios and Specifications
13.18.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Bio-Labs Main Business Overview
13.18.5 Bio-Labs Latest Developments
13.19 Pusvetma
13.19.1 Pusvetma Company Information
13.19.2 Pusvetma Avian Influenza Vaccines Product Portfolios and Specifications
13.19.3 Pusvetma Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Pusvetma Main Business Overview
13.19.5 Pusvetma Latest Developments
13.20 IPB-Shigeta
13.20.1 IPB-Shigeta Company Information
13.20.2 IPB-Shigeta Avian Influenza Vaccines Product Portfolios and Specifications
13.20.3 IPB-Shigeta Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 IPB-Shigeta Main Business Overview
13.20.5 IPB-Shigeta Latest Developments
13.21 Medion Farma Jaya
13.21.1 Medion Farma Jaya Company Information
13.21.2 Medion Farma Jaya Avian Influenza Vaccines Product Portfolios and Specifications
13.21.3 Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Medion Farma Jaya Main Business Overview
13.21.5 Medion Farma Jaya Latest Developments
13.22 Caprifamarindo
13.22.1 Caprifamarindo Company Information
13.22.2 Caprifamarindo Avian Influenza Vaccines Product Portfolios and Specifications
13.22.3 Caprifamarindo Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Caprifamarindo Main Business Overview
13.22.5 Caprifamarindo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Avian Influenza Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Avian Influenza Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of H5+H7 Avian Influenza Vaccines
Table 4. Major Players of H9 Avian Influenza Vaccines
Table 5. Global Avian Influenza Vaccines Sales byType (2020-2025) & (M Doses)
Table 6. Global Avian Influenza Vaccines Sales Market Share byType (2020-2025)
Table 7. Global Avian Influenza Vaccines Revenue byType (2020-2025) & ($ million)
Table 8. Global Avian Influenza Vaccines Revenue Market Share byType (2020-2025)
Table 9. Global Avian Influenza Vaccines Sale Price byType (2020-2025) & (USD/K Doses)
Table 10. Global Avian Influenza Vaccines Sale by Application (2020-2025) & (M Doses)
Table 11. Global Avian Influenza Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global Avian Influenza Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global Avian Influenza Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global Avian Influenza Vaccines Sale Price by Application (2020-2025) & (USD/K Doses)
Table 15. Global Avian Influenza Vaccines Sales by Company (2020-2025) & (M Doses)
Table 16. Global Avian Influenza Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global Avian Influenza Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Avian Influenza Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global Avian Influenza Vaccines Sale Price by Company (2020-2025) & (USD/K Doses)
Table 20. Key Manufacturers Avian Influenza Vaccines Producing Area Distribution and Sales Area
Table 21. Players Avian Influenza Vaccines Products Offered
Table 22. Avian Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Avian Influenza Vaccines Sales by Geographic Region (2020-2025) & (M Doses)
Table 26. Global Avian Influenza Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global Avian Influenza Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Avian Influenza Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Avian Influenza Vaccines Sales by Country/Region (2020-2025) & (M Doses)
Table 30. Global Avian Influenza Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global Avian Influenza Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Avian Influenza Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 34. Americas Avian Influenza Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas Avian Influenza Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Avian Influenza Vaccines Sales byType (2020-2025) & (M Doses)
Table 37. Americas Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 38. APAC Avian Influenza Vaccines Sales by Region (2020-2025) & (M Doses)
Table 39. APAC Avian Influenza Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC Avian Influenza Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Avian Influenza Vaccines Sales byType (2020-2025) & (M Doses)
Table 42. APAC Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 43. Europe Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 44. Europe Avian Influenza Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Avian Influenza Vaccines Sales byType (2020-2025) & (M Doses)
Table 46. Europe Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 47. Middle East & Africa Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
Table 48. Middle East & Africa Avian Influenza Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Avian Influenza Vaccines Sales byType (2020-2025) & (M Doses)
Table 50. Middle East & Africa Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of Avian Influenza Vaccines
Table 52. Key Market Challenges & Risks of Avian Influenza Vaccines
Table 53. Key IndustryTrends of Avian Influenza Vaccines
Table 54. Avian Influenza Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Avian Influenza Vaccines Distributors List
Table 57. Avian Influenza Vaccines Customer List
Table 58. Global Avian Influenza Vaccines SalesForecast by Region (2026-2031) & (M Doses)
Table 59. Global Avian Influenza Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Avian Influenza Vaccines SalesForecast by Country (2026-2031) & (M Doses)
Table 61. Americas Avian Influenza Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Avian Influenza Vaccines SalesForecast by Region (2026-2031) & (M Doses)
Table 63. APAC Avian Influenza Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Avian Influenza Vaccines SalesForecast by Country (2026-2031) & (M Doses)
Table 65. Europe Avian Influenza Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Avian Influenza Vaccines SalesForecast by Country (2026-2031) & (M Doses)
Table 67. Middle East & Africa Avian Influenza Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Avian Influenza Vaccines SalesForecast byType (2026-2031) & (M Doses)
Table 69. Global Avian Influenza Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Avian Influenza Vaccines SalesForecast by Application (2026-2031) & (M Doses)
Table 71. Global Avian Influenza Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Boehringer Ingelheim Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Boehringer Ingelheim Avian Influenza Vaccines Product Portfolios and Specifications
Table 74. Boehringer Ingelheim Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 75. Boehringer Ingelheim Main Business
Table 76. Boehringer Ingelheim Latest Developments
Table 77. CAHIC Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. CAHIC Avian Influenza Vaccines Product Portfolios and Specifications
Table 79. CAHIC Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. CAHIC Main Business
Table 81. CAHIC Latest Developments
Table 82. DHN Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. DHN Avian Influenza Vaccines Product Portfolios and Specifications
Table 84. DHN Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 85. DHN Main Business
Table 86. DHN Latest Developments
Table 87. HVRI Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. HVRI Avian Influenza Vaccines Product Portfolios and Specifications
Table 89. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 90. HVRI Main Business
Table 91. HVRI Latest Developments
Table 92. CEVA Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. CEVA Avian Influenza Vaccines Product Portfolios and Specifications
Table 94. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 95. CEVA Main Business
Table 96. CEVA Latest Developments
Table 97. Elanco Animal Health Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Elanco Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
Table 99. Elanco Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 100. Elanco Animal Health Main Business
Table 101. Elanco Animal Health Latest Developments
Table 102. Zoetis Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Zoetis Avian Influenza Vaccines Product Portfolios and Specifications
Table 104. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 105. Zoetis Main Business
Table 106. Zoetis Latest Developments
Table 107.FATRO Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108.FATRO Avian Influenza Vaccines Product Portfolios and Specifications
Table 109.FATRO Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 110.FATRO Main Business
Table 111.FATRO Latest Developments
Table 112. Kyoto Biken Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Kyoto Biken Avian Influenza Vaccines Product Portfolios and Specifications
Table 114. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 115. Kyoto Biken Main Business
Table 116. Kyoto Biken Latest Developments
Table 117. CAVAC Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. CAVAC Avian Influenza Vaccines Product Portfolios and Specifications
Table 119. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. CAVAC Main Business
Table 121. CAVAC Latest Developments
Table 122. Ringpu Biology Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Ringpu Biology Avian Influenza Vaccines Product Portfolios and Specifications
Table 124. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 125. Ringpu Biology Main Business
Table 126. Ringpu Biology Latest Developments
Table 127. Vaksindo Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Vaksindo Avian Influenza Vaccines Product Portfolios and Specifications
Table 129. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 130. Vaksindo Main Business
Table 131. Vaksindo Latest Developments
Table 132. Sindh Poultry Vaccine Centre Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolios and Specifications
Table 134. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 135. Sindh Poultry Vaccine Centre Main Business
Table 136. Sindh Poultry Vaccine Centre Latest Developments
Table 137. Merck Animal Health Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. Merck Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
Table 139. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 140. Merck Animal Health Main Business
Table 141. Merck Animal Health Latest Developments
Table 142. PT MedionFarma Jaya Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. PT MedionFarma Jaya Avian Influenza Vaccines Product Portfolios and Specifications
Table 144. PT MedionFarma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 145. PT MedionFarma Jaya Main Business
Table 146. PT MedionFarma Jaya Latest Developments
Table 147. Avimex Animal Health Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. Avimex Animal Health Avian Influenza Vaccines Product Portfolios and Specifications
Table 149. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 150. Avimex Animal Health Main Business
Table 151. Avimex Animal Health Latest Developments
Table 152. JOVAC Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 153. JOVAC Avian Influenza Vaccines Product Portfolios and Specifications
Table 154. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 155. JOVAC Main Business
Table 156. JOVAC Latest Developments
Table 157. Bio-Labs Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 158. Bio-Labs Avian Influenza Vaccines Product Portfolios and Specifications
Table 159. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 160. Bio-Labs Main Business
Table 161. Bio-Labs Latest Developments
Table 162. Pusvetma Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 163. Pusvetma Avian Influenza Vaccines Product Portfolios and Specifications
Table 164. Pusvetma Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 165. Pusvetma Main Business
Table 166. Pusvetma Latest Developments
Table 167. IPB-Shigeta Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 168. IPB-Shigeta Avian Influenza Vaccines Product Portfolios and Specifications
Table 169. IPB-Shigeta Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 170. IPB-Shigeta Main Business
Table 171. IPB-Shigeta Latest Developments
Table 172. MedionFarma Jaya Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 173. MedionFarma Jaya Avian Influenza Vaccines Product Portfolios and Specifications
Table 174. MedionFarma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 175. MedionFarma Jaya Main Business
Table 176. MedionFarma Jaya Latest Developments
Table 177. Caprifamarindo Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 178. Caprifamarindo Avian Influenza Vaccines Product Portfolios and Specifications
Table 179. Caprifamarindo Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 180. Caprifamarindo Main Business
Table 181. Caprifamarindo Latest Developments
LIST OFFIGURES
Figure 1. Picture of Avian Influenza Vaccines
Figure 2. Avian Influenza Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Avian Influenza Vaccines Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Avian Influenza Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Avian Influenza Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Avian Influenza Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Avian Influenza Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of H5+H7 Avian Influenza Vaccines
Figure 12. Product Picture of H9 Avian Influenza Vaccines
Figure 13. Global Avian Influenza Vaccines Sales Market Share byType in 2025
Figure 14. Global Avian Influenza Vaccines Revenue Market Share byType (2020-2025)
Figure 15. Avian Influenza Vaccines Consumed in Chicken
Figure 16. Global Avian Influenza Vaccines Market: Chicken (2020-2025) & (M Doses)
Figure 17. Avian Influenza Vaccines Consumed in Duck & Goose
Figure 18. Global Avian Influenza Vaccines Market: Duck & Goose (2020-2025) & (M Doses)
Figure 19. Avian Influenza Vaccines Consumed in Other
Figure 20. Global Avian Influenza Vaccines Market: Other (2020-2025) & (M Doses)
Figure 21. Global Avian Influenza Vaccines Sale Market Share by Application (2024)
Figure 22. Global Avian Influenza Vaccines Revenue Market Share by Application in 2025
Figure 23. Avian Influenza Vaccines Sales by Company in 2025 (M Doses)
Figure 24. Global Avian Influenza Vaccines Sales Market Share by Company in 2025
Figure 25. Avian Influenza Vaccines Revenue by Company in 2025 ($ millions)
Figure 26. Global Avian Influenza Vaccines Revenue Market Share by Company in 2025
Figure 27. Global Avian Influenza Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Avian Influenza Vaccines Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Avian Influenza Vaccines Sales 2020-2025 (M Doses)
Figure 30. Americas Avian Influenza Vaccines Revenue 2020-2025 ($ millions)
Figure 31. APAC Avian Influenza Vaccines Sales 2020-2025 (M Doses)
Figure 32. APAC Avian Influenza Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Europe Avian Influenza Vaccines Sales 2020-2025 (M Doses)
Figure 34. Europe Avian Influenza Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Avian Influenza Vaccines Sales 2020-2025 (M Doses)
Figure 36. Middle East & Africa Avian Influenza Vaccines Revenue 2020-2025 ($ millions)
Figure 37. Americas Avian Influenza Vaccines Sales Market Share by Country in 2025
Figure 38. Americas Avian Influenza Vaccines Revenue Market Share by Country (2020-2025)
Figure 39. Americas Avian Influenza Vaccines Sales Market Share byType (2020-2025)
Figure 40. Americas Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 41. United States Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Avian Influenza Vaccines Sales Market Share by Region in 2025
Figure 46. APAC Avian Influenza Vaccines Revenue Market Share by Region (2020-2025)
Figure 47. APAC Avian Influenza Vaccines Sales Market Share byType (2020-2025)
Figure 48. APAC Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 49. China Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. India Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Avian Influenza Vaccines Sales Market Share by Country in 2025
Figure 57. Europe Avian Influenza Vaccines Revenue Market Share by Country (2020-2025)
Figure 58. Europe Avian Influenza Vaccines Sales Market Share byType (2020-2025)
Figure 59. Europe Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 60. Germany Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61.France Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Avian Influenza Vaccines Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Avian Influenza Vaccines Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
Figure 68. Egypt Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Avian Influenza Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Avian Influenza Vaccines in 2025
Figure 74. Manufacturing Process Analysis of Avian Influenza Vaccines
Figure 75. Industry Chain Structure of Avian Influenza Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Avian Influenza Vaccines Sales MarketForecast by Region (2026-2031)
Figure 78. Global Avian Influenza Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Avian Influenza Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Avian Influenza Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Avian Influenza Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Avian Influenza Vaccines Revenue Market ShareForecast by Application (2026-2031)
